Cotellic 20 MG tablet 63S
Ended Awarded
- Contract number
- SPE2DB26FYM45
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,561
Award facts
- Contract value 100% obligated
- $11,561.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,561.08 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cotellic 20 mg tablets (63-count units). The delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement competition. DMS Pharmaceutical Group Inc. was selected as the awardee under its position as a regional prime vendor contractor within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
This delivery order is issued under DMS Pharmaceutical Group's indefinite delivery contract (IDC) designated SPE2DR, a single-award contract valued at $499,999,999 with a completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion Defense Logistics Agency acquisition strategy designed to establish multiple regional prime vendor contractors supplying comprehensive pharmaceutical products, including branded and generic prescription medications, biologics, and medical consumables to support Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group's established performance on numerous delivery orders demonstrates its capability as a critical supplier within the federal pharmaceutical supply chain supporting recurring medical supply needs across the global military medical system.
Quick answers
Who was awarded contract SPE2DB26FYM45?
SPE2DB26FYM45 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FYM45 worth?
The government has obligated $11,561 on SPE2DB26FYM45.
Is contract SPE2DB26FYM45 an order under another contract?
Yes. SPE2DB26FYM45 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB26FYM45 competed?
The extent of competition for SPE2DB26FYM45 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award